Delivery Order SPE2DB24D1205-SPE2DB25FDAVG
- Not listed
- The Defense Logistics Agency awarded a $1,385.52 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Orgovyx 120 mg tablets (30-count unit of use packaging). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract requires no set-aside designation, indicating the award was made through open...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg on August 19, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, reflecting the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $8,313.12 for 30 tablets of Orgovyx 120 mg on September 12, 2025, with an ultimate completion date of October 3, 2025. This non-competitive award was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The delivery order will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,385.52, represents a non-competitive set-aside award and is scheduled for completion by October 2, 2025. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for 30-tablet units of Orgovyx 120 mg tablets. This non-competitive, firm fixed-price delivery order was executed on September 25, 2025, with an ultimate completion date of October 17, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for 30-unit supplies of Orgovyx 120 mg tablets. The contract, issued on September 11, 2025, with completion targeted for October 2, 2025, carries firm fixed pricing and represents a non-competitive set-aside delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52 and a firm fixed price structure. This delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), is scheduled for completion by September 12, 2025. The award was made through open competition with...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside contract represents a purchase of pharmaceutical products to support federal medical procurement needs, with performance to occur at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-unit pack) on August 27, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded contract for pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52. This delivery order was competitively awarded with firm fixed pricing and is scheduled for completion by September 16, 2025. The contract was awarded on August 25, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDAVGDelivery Order
The Defense Logistics Agency awarded a $1,385.52 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg on September 24, 2025, with an ultimate completion date of October 16, 2025. This firm fixed price, competitively awarded contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with DLA. The contract specifies performance at the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its primary operations as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026. The IDC enables AmerisourceBergen to supply pharmaceutical products and medical commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. Orgovyx, a prescription medication for prostate cancer treatment, represents one of the specialized pharmaceutical products within the broader therapeutic domains covered under the company's comprehensive federal supply agreement. No set-aside designation was applied to this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/24/25 |